Visiopharm review
A research-focused pathology suite for trainable AI, multiplex analysis and scaled studies.
Reviewed by iTechGuides Editors · Editorial team · Updated Nov 2026
Visiopharm provides AI-driven software for digital pathology research and diagnostics. Its Discovery and Phenoplex platforms support tissue-image analysis, deep-learning application (APP) training, region and cell segmentation, biomarker quantification, serial-section alignment and batch study processing. Research scientists and pathologists can use it to build custom workflows, while specific applications address biomarker assessment in breast, lung and prostate cancer. The product is aimed at research pathology labs and mid-market or enterprise organizations.
The feature set centers on trainable analysis and specialized pathology workflows. Quickstart APPs provide preconfigured segmentation and detection starting points, while users can train deep-learning APPs for tissue image analysis. Phenoplex handles multiplex and spatial-biology images; Tissuealign aligns serial sections; and Tissuearray manages tissue microarrays and batch analysis. Interactive plots connect measurements back to image cells, and batch and parallel processing support work across studies. Ecosystem fit includes IMS/PACS integrations with Sectra and Proscia, plus connections involving PathAI, Philips, Smart in Media, Fujifilm, Corista and Paige.
Deployment can span web, Windows, API and self-hosted environments, with cloud, on-premises and hybrid options. Support channels include email, phone, tickets and documentation, and the company lists ISO 27001 compliance. Pricing follows a contact-sales model through demos or quotes. Visiopharm is a strong fit for teams that need customizable pathology AI, multiplex analysis and integrated study operations. Organizations seeking open-source software, self-service pricing or a narrowly focused image-analysis utility may prefer a simpler alternative. Most products are positioned for research use, although specific APPs carry IVDR-certified CE-IVD status.
Visiopharm pros and cons
- Where it wins
- Trainable deep-learning APPs plus Quickstart segmentation and detection tools
- Phenoplex multiplex analysis, Tissuealign, Tissuearray and linked cell plots
- Integrations with Sectra, Proscia, PathAI, Philips and other IMS/PACS systems
- Where it doesn't
- Pricing is handled through demos or sales quotes rather than published plans
- Products are generally research-use-only unless specifically indicated
- No open-source edition is available for direct code-level modification
Visiopharm fact sheet, pricing and score →
Advertiser disclosure: iTechGuides is reader-supported. Vendors can pay for top positions in our rankings and for a place on other products' pages, and we may earn a commission when you click some links. Bought places stand at the number bought; this page and our disclosure say so. Paying vendors may get a fuller, more detailed review from our editors, and that review can change their score. How we rank.
Last updated · How we research and update